Some lawmakers are less bold when their party is in power.
The California lawmaker was the first to hear Blasey's allegation of sexual assault against Brett Kavanaugh.
Maybe it's what you'd expect from Silicon Valley's representative in Congress, but Congresswoman Anna Eshoo really understands the intimate connection between public policy and our digital future.
(Reporting By Diane Bartz; editing by Andrew Hay) For example, it settled with the FTC following privacy gaffes during the
It is undeniable that the communication industry has brought transformational benefits to consumers, and the future of the industry is boundless. Policymakers, however, continue to have a pivotal role either as catalysts for investment and innovation or creating potential hurdles to new technology
WASHINGTON -- Hidden within the mammoth omnibus appropriations bill crafted by House, Senate and White House negotiators
The draft executive order, which leaked out of the White House in April, would require any organization seeking a contract
The lawmakers made clear that the money spent from the treasuries of publicly traded companies is shareholder money, not
Democrats in Congress have just proudly signed a deal that allows a bunch of old men who have spent the better part of the last century avoiding their own sexual issues to dictate access to abortion services.
Thank you, Rep. Eshoo, for your commitment to having a bill that does not allow for "evergreening." Now the question becomes -- how are we going to get one?
In Congress, I will work to support affordable prices on biologics, so that victims of cancer, HIV, diabetes, Parkinsons, rheumatoid arthritis, and multiple sclerosis can afford the medicine they need to stay alive.
Jane Hamsher attributes nefarious motives to our health care reform effort and the resulting legislation. I fiercely disagree. It was carefully shaped to save lives and reduce costs.
The public option has received the lion's share of attention in the health care debate, but there's an equally important issue relating to generic drugs that could mean lifesaving drugs remain too expensive for all but the wealthy.
Pelosi made a choice about the lifesaving biologic drugs I took when I was in chemotherapy that will cost many fellow breast cancer survivors everything they own, and quite possibly their lives.
The Eshoo/Barton amendment, which has the support of many newly pro-PhRMA democrats, will extend the period of monopolies for biologic medicines.
Unlike for pharmaceutical drugs, there is no easy way to get FDA approval for a generic biologic product. Congress is considering an FDA reform to fix this, but it is being derailed by the BIO.